CompoAtlas

Toux Grasse — Mélange d'herbes expectorantes

Food supplement declared in France, decision dated 30 May 2026

Toux Grasse — Mélange d'herbes expectorantes (Medycyna Ziołowa) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Polygonum aviculare 1,000 mg per day, Primula officinalis 1,000 mg per day, Sambucus nigra 1,000 mg per day, Verbascum thapsus 1,000 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Medycyna Ziołowa
Food business operator placing the product on the market
KBZ Systems Sp. z o.o.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Autre : Mélange d'herbes en vrac à infuser
Daily dose
1 à 2 tasses par jour, soit environ 2 à 4 g de mélange
Directions for use
Verser 1 cuillère à café (≈2 g) du mélange dans 250 ml d'eau chaude (≈95°C). Laisser infuser à couvert pendant 10 minutes. Filtrer. Consommer 1 à 2 tasses par jour, de préférence avant 16h pour ne pas affecter le sommeil.
Intended populations
Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Respiratory tract, Immunity

Declaration 366486, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Polygonum aviculare L.Parties aériennesPartie de plante en l'état1,000 mg
Primula officinalis (L.) Hill.FleurPartie de plante en l'état1,000 mg
Sambucus nigra L.FleurPartie de plante en l'état1,000 mg
Verbascum thapsus L.FleurPartie de plante en l'état1,000 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé en cas de grossesse ou d'allaitement. Déconseillé aux enfants de moins de 12 ans. En cas de toux persistante au-delà d'une semaine ou s'accompagnant de fièvre, consulter un médecin. La racine de primevère contient des saponines : en cas d'ulcère gastro-duodénal ou de gastrite, consulter un médecin avant utilisation. En cas de prise concomitante de traitements médicamenteux, consulter un pharmacien. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Ne se substitue pas à une alimentation variée et équilibrée. Conserver dans un endroit sec, à l'abri de la lumière et de la chaleur.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sambucus nigra L.
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Medycyna Ziołowa

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Toux Grasse — Mélange d'herbes expectorantes (Medycyna Ziołowa): composition and regulation”, https://compoatlas.com/en/supplements/products/366486-toux-grasse-melange-d-herbes-expectorantes, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line